Will Oracle Offload Cerner to Fund Datacenters?

The rumor mill was working overtime last week after a TD Cowen research note claimed that Oracle will have to offload Oracle Health – formerly known as Cerner – to fund its AI datacenter commitments.

It’s a tale of the times. A research note isn’t an official announcement, but the EHR market could be heading towards its biggest shakeup since Oracle first acquired Cerner in 2022.

  • The speculation revolves around Oracle’s massive $300B datacenter contract with OpenAI, which will apparently take $156B of capital expenditures to fulfill.
  • Add in contracts with Meta and Nvidia, and Oracle’s commitments swell to over $500B.

That’s a ton of CapEx. TD Cowen says Oracle will have to make some deep cuts to round up enough funds. That includes:

  • Selling Cerner to the highest bidder
  • Axing up to 30k jobs, about 15% of the current workforce
  • Exploring “bring your own chip” arrangements to lighten the load on Oracle’s books

Oracle’s back is against the wall. It’s already raised $58B in the last two months, and U.S. banks have started pulling back their lending.

  • Foreign banks are still supporting Oracle’s datacenter projects, but they’ve also raised their premiums to levels typically reserved for non-investment grade companies.
  • On top of that, Oracle is going to have a hard time recouping the $28B it just paid for Cerner. Since the acquisition, Cerner’s had a brutal VA implementation, a tough rollout with the DoD, and Epic’s been eating its lunch.

Who has deep enough pockets to acquire Cerner? It’s a short list.

  • Microsoft is a prime suspect. It’s already heavily invested in healthcare through Nuance and Azure, so an EHR could potentially create a compelling end-to-end cloud lineup for its existing customers.
  • Google and Amazon also probably wouldn’t mind having Cerner’s customer base as an anchor for their cloud ambitions. They both have full war chests and established healthcare ventures like Verily and One Medical, but they also share a track-record of expensive lessons in the industry. 

The Takeaway

Recent struggles aside, Cerner is one of healthcare’s true industry titans. It shaped decades of innovation and thousands of careers. Now it might end up as a line item to fund GPU clusters.

Crystal Ball Compilation: Digital Health in 2026 

Welcome back to the first Digital Health Wire of 2026! The healthcare industry doesn’t take any days off, but we hope our readers managed to catch a break over the holidays to recharge for the big things to come in the new year.

The past few weeks have had plenty of fortune tellers predicting what those big things will be, so we’re kicking off the year with a compilation of the clearest crystal balls.

Let’s get right into it.

CommonSpirit HealthFive Health Tech Predictions for 2026, Dr. Minal Shah

  • Favorite Forecast: In 2026, AI projects without strategic alignment are heading straight to the pilot graveyard. When organizations chase what’s possible instead of what’s strategic, they burn human capital on change efforts that never scale to real impact.
  • Big Idea: “Platform vs. point solution is a false dichotomy – and I think we’re asking the wrong question. The real question isn’t which approach to take. It’s whether we’ve done the hard work of understanding what the organization actually needs before we choose a path forward. That means moving from ‘what can we do with AI?’ to ‘what should we be doing with AI?'”

Out-of-PocketOut-Of-Pocket’s 2026 Predictions, Nikhil Krishnan

  • Favorite Forecast: Intellectual property lines will be drawn for AI. We’ve already seen a ton of legal battles around copyrights, but the dealmaking is just getting started.
  • Big Idea: “Healthcare has a TON of companies that have copyrights and IP ownership over critical parts of healthcare information. OpenEvidence for example has signed several agreements with medical societies, NEJM, etc. Who will the AMA partner with for CPT codes? Which companies will the EHRs partner with to license their data?”

Second OpinionHealthcare in 2026, Christina Farr & Annalisa Merelli

  • Favorite Forecast: The largest digital health companies will start flocking to CMS’ new ACCESS program to find a better business model in Medicare, while also duking it out for a slice of the available rural health funding. 
  • Big Idea: “There’s no question digital health companies will be the beneficiaries, particularly given that the executive and policymaker running Medicare – Chris Klomp – has an entrepreneurial background and formerly sat on the board of venture-backed Maven Clinic.”

Becker’sHow the AI conversation will change in 2026, Zachary Lipton

  • Favorite Forecast: Clinical decision support has been trapped in a frustrating middle zone for years: better than manually searching guidelines, but worse than talking to a specialist. CDS will finally start evolving beyond search with contextual awareness.
  • Big Idea: “This is the year CDS evolves past glamorized search. Next-generation CDS will reason jointly over medical literature, the patient’s record and current visit context, helping clinicians apply knowledge, not just retrieve it.”

Forbes 10 Healthcare Industry Predictions For 2026, Sachin Jain

  • Favorite Forecast: Healthcare’s AI revolution will hit speed bumps. While AI has shown considerable promise for relatively straightforward uses like ambient dictation, its application in other domains will be more challenged and problematic.
  • Big Idea: “Agentic AI holds significant promise, but legacy operators will be slow to change deeply ingrained processes, values, and attitudes. AI snake-oil salespeople (fueled by venture capitalists chasing outsized returns) have flooded the zone, a phenomenon that is sure to fuel false starts and threaten the pace and depth of true organizational change in the short-run.”

Hospitalogy8 Predictions for Healthcare 2026, Blake Madden

  • Favorite Forecast: In 2026, enterprise buyers will start demanding consolidation. The operational model shifts from “best of breed for each use case” to “who can orchestrate AI across our entire administrative and clinical workflow?”
  • Big Idea: “This is where the Palantir playbook becomes relevant. The firm is already working with HCA and others to deploy AI infrastructure that spans clinical, operational, and financial domains. The value proposition isn’t any single algorithm. It’s the orchestration layer that ties disparate data sources into unified decision support.”

Notable Healthcare’s pivotal year for AI transformation, Dr. Aaron Neinstein

  • Favorite Forecast: New practices will be built from scratch around AI Agents to support panel sizes three to five times larger at equal or higher quality and dramatically lower cost. At the same time, human connection will take center stage again.
  • Big Idea: “AI will handle pattern analysis and routine adjustments, so clinicians can shift from memorizing facts to focusing on meaning… Because of this, nurses, MAs, and care coordinators will move up the value chain, as they can spend more time on empathy, clinical judgement, and complex situations rather than administrative tasks.”

The Takeaway

Healthcare still has its fair share of challenges, but it has just as many tailwinds pushing it toward new solutions. Cheers to everyone making those solutions a reality in the new year.

Rock Health: Innovation at the Turn of 2026

Rock Health is wrapping up the year in style by updating its Innovation Maturity Curve with the hottest trends of 2025 and sharing its predictions for what lies ahead.

The curve uses three major data points to plot innovation:

  • Research volume – gauges the potential of a topic through PubMed publications.
  • Venture funding – tracks investment as a leading indicator of commercial interest.
  • Partnership activity – uses industry partnerships as a proxy for commercial traction.

The pace is picking up. Here’s a look at the categories that defined the year:

Longevity (Maturity Score: Developing) – Companies are pushing past one-off diagnostics to see whether personalized baselines can anchor ongoing care. Function Health just hauled in a massive $298M Series B for its “operating system for human health,” and other players like Hone Health have started expanding their models with in-home services.

  • Keep an eye on: How much will insights on hormones or heart health translate into adjustments that patients actually act on? Rock Health expects this segment to hinge on turning long-arc patterns into timely guidance that’s both credible and valuable.

Mental Health Chatbots (Maturity Score: Emerging) – Some AI chatbots might be shutting down, but just as many are doubling down. Slingshot burst onto the scene with $93M to build “the world’s first foundation model for psychology,” and incumbents like Spring Health have even started launching bots to evaluate the safety of other bots.

  • Keep an eye on: Regulatory scrutiny is intensifying as states begin banning AI-driven therapy. Some startups might be able to navigate the roadblocks, but Rock Health thinks others might pivot to lower-risk territory like keeping patients engaged between visits.

Health Benefits 2.0 (Maturity Score: Emerging) – OOP spending continues to climb, while employers just notched the steepest benefit cost increase in 15 years. Those pressures cracked a window for non-traditional models to gain traction, such as ICHRA frontrunners Thatch and Venteur.

  • Keep an eye on: The benefits pressure cooker is heating up in 2026, which means this category isn’t going anywhere. As more costs shift to consumers, Rock Health anticipates the benefits experience to start looking even more like a set of adjacent marketplaces rather than a single plan.

The Takeaway 

Digital health is moving faster than ever, and AI is only going to keep accelerating innovation. Rock Health’s full report is well worth checking out for more details on these categories and other up-and-coming segments like wearables (smart rings are especially hot), precision medicine (digital twins had a big year), and climate health (think allergies and air pollution).

TrumpRx and the GLP-1 Land Grab

It’s a bad day to be a pharma middleman. The White House announced the launch of TrumpRx in 2026, kicking off a wave of cost reductions on some of the most popular drugs in the world. 

TrumpRx looks exactly like it sounds. Here’s the website.

  • The site will serve as a portal for patients to find the best rates on prescription medications, AKA “Most-Favored-Nation Pricing.” 
  • Unlike other billionaire-run pharma projects like Mark Cuban Cost Plus Drug Company, TrumpRx won’t actually fulfill anything. 
  • Instead, it will send people to pharmaceutical companies’ direct-to-consumer sites to process orders, a strategy that Cuban applauded as having “no downside for anyone.” 

It gets better. TrumpRx was part of a broader initiative to lower drug costs for Americans, and included major partnerships with Novo Nordisk and Eli Lilly to expand access to GLP-1s.

  • Novo’s Ozempic and Wegovy will be listed at $350 per month on TrumpRx, significantly lower than the $1k per month that many patients are used to.
  • The same goes for Lilly’s Zepbound, and both manufacturers agreed to list their upcoming oral GLP-1s at $150 “in the event that the FDA later approves them.” That seems pretty likely at this point.

What does pharma get out of it? Medicare coverage.

  • The “historic reductions” will enable Medicare and Medicaid to cover GLP-1s for adults with obesity, as opposed to confining coverage to those with diabetes or heart disease.  

Things snowballed from there. Novo revealed this week that it will immediately slash its GLP-1s to $349 on its DTC platform, with doses available at $199 for new patients.

  • GoodRx was quick to match them at $199 for the first two months, and Ro hopped on the same introductory bandwagon.
  • Omada also completely changed its tune within hours of the TrumpRx announcement and said that it will begin prescribing GLP-1s for the first time in 2026.

The Takeaway

The GLP-1 landscape just got tossed on its head, and the oral versions haven’t even come out yet. Drug manufacturers are already throwing down the direct-to-consumer gauntlet, but so far it looks like patients might actually come out on top.

U.S. Healthcare is an “Abominable Creature”

If a picture is worth a thousand words, then this chart from industry consultant Andrew Tsang might be worth a million.

America’s healthcare system is “An Abominable Creature.” That’s also the title of Tsang’s stellar blog post that meticulously maps out every dollar that flows through it.

  • The flows in the diagram represent $4.9T, but they’re also a glimpse at every medical decision that was made in the U.S. last year. Every diagnosis. Every birth. Every death.

The charts don’t just map spending, they map our decisions. We built the healthcare system brick by brick with the choices we made, and although they might have all made sense individually, the end result is a monster of our own design.

Decision 1 – Workers fund healthcare twice… or more [Chart 1]. 

  • Federal, State, and Local Taxes – $2.4T for Medicare, Medicaid, and public health.
  • Payroll Taxes – employers fund Medicare even though most employees aren’t 65.
  • Premiums – $688B gets deducted from paychecks for employer plans.
  • Out-of-Pocket Costs – Americans shell out another $506B when they actually get care.

Decision 2 – We look after our seniors [Chart 2]. 

  • Medicare accounts for $1T every year.
  • Nursing homes account for $218B every year.
  • Home health & hospice account for $100B (and 22% of all Medicaid spending).

Other Decisions – The full U.S. diagram can tell whatever story you want it to [Chart 3].

  • Treatment is more important than prevention – $100B goes to public health while $1.5T goes to hospital care annually.
  • Innovation is a bigger priority than price controls – $441B is spent on prescription drugs.
  • Repairing old age is better than investing in children – $120B goes to children’s health compared to $1T for Medicare.

The Takeaway

The U.S. healthcare system was pieced together through a long chain of isolated decisions, each one solving a specific problem at the time. Tsang just gave us a beautiful illustration of the end result: a kraken with countless tentacles that all seem to have a mind of their own.

HLTH 2025 Recap and Major Announcements

Hard to believe that was already Digital Health Wire’s fourth trip to HLTH – a few more flights out to Vegas and we might be getting close to “legacy media” status.

The more the conversations change, the more they stay the same. Last year’s “Be Bold” theme and LLM mania gave way to tales from healthcare’s “Heroes and Legends” and an AI agent avalanche.

The industry is still facing most of the same challenges, but it was amazing to see how quickly new innovations are compounding in the solutions that it’s using to conquer them.

Here’s our (non-exhaustive) roundup of some of those solutions from the expo hall:

  • Arbital Health debuted its Merlin AI value-based care assistant built to make actuarial analysis transparent and actionable. Merlin AI interprets complex risk contract data, explains performance drivers, and instantly recommends next best steps.
  • Abridge is bringing CDS into the flow of clinical conversations through a partnership with Wolters Kluwer. The UpToDate integration adds to a white-hot October for Abridge, which already included heavy-hitter roll outs at UPMC and Northwell.
  • Brook.ai hauled in $28M of Series B funding to expand its personalized remote care platform to more patients and conditions. Providers can get up and running on the platform in 30 days with no CapEx required, and the results in the announcement speak for themselves. More to come on this one next week.
  • Cedar debuted an aptly named Cedar Cover enrollment tool to make sure patients aren’t caught in the rain when the dark cloud of Medicaid cuts gets here. Cedar Cover’s key capabilities include Medicaid enrollment, proactive renewal, and denials resolution.
  • Ellipsis Health is teaming up with NVIDIA to leverage its Parakeet ASR model and build out the AI infrastructure supporting Sage, an emotionally intelligent AI care manager that expands staffing capacity through proactive patient engagement.
  • GE HealthCare is collaborating with The Queen’s Health Systems and Duke Health to advance the development of its upcoming AI-driven hospital operations solution. The solution will leverage insights from both systems and the 500+ hospitals using Command Center to surface actions for improving care quality, patient flow, and resource utilization. 
  • hc1 unveiled hc1 IQ to deliver precision insights that transform lab data into life-saving action. hc1 IQ unifies lab, clinical, and supply chain data into a single AI-powered platform to produce enterprise-wide intelligence for improving outcomes.
  • IntelePeer launched a SmartAnalytics Starter Pack that gives providers the most approachable entry-point we’ve seen to the AI agent ecosystem. It includes one patient engagement automation from IntelePeer’s menu, along with real-time dashboards and call analysis to drive immediate operational improvements.
  • League introduced League Agent Teams to its AI-first consumer experience platform. The multi-agent system guides users through complex health journeys using a suite of AI agents fine-tuned for specific tasks and an orchestration layer to coordinate them.  
  • Lorikeet debuted a healthcare-specific extension for its Team of Agents (deja vu, definitely one of the biggest themes at HLTH), which coordinates actions across multiple agents to call vendors, text doctors, and take action to “actually solve customer issues.”
  • Nabla debuted Nabla Connect, a plug-and-play module that enables any EHR to seamlessly integrate ambient AI. Nabla already has one of the widest EHR footprints in the space, and CEO Alex LeBrun gave us the live walkthrough of how Nabla Connect extends that foundation to smaller EHRs looking to unlock the same capabilities.
  • Optum took the lid off its Optum Real claims system that delivers instant coverage validation. The multi-payor platform enables real-time data exchange between payers and providers, allowing any issues to be intercepted at the point of submission.
  • Penguin Ai is joining forces with UPMC Enterprises and leveraging its Ahavi data platform to validate new AI models in a secure testing environment. Ahavi will allow Penguin to refine its Small Language Models for real clinical use cases like record summarization and prior auth optimization.
  • Solera Health showcased its Precision Insights Suite for AI-driven cost containment and care navigation. The two core components include Precision Intercept, which identifies patients at risk of significantly increasing costs within a year, and Precision Navigate, which delivers personalized provider recommendations based on similar patients.
  • Suki launched a nursing-focused AI consortium with several leading health systems and AvaSure on the inaugural roster. The consortium will co-develop Suki for Nurses while integrating ambient AI capabilities into AvaSure’s virtual care platform.
  • Vital announced the launch of Vital Urgent Care, an AI-powered platform that provides patients in urgent care settings with real-time updates, wait times, and personalized guidance – without requiring a single download or additional staff bandwidth.
  • Wellsheet is rolling out across Ascension to give providers a unified view of previously overlooked data. The “GenAI front-end” allows care teams to access patient-specific EHR data on a single screen, accelerating diagnoses and clinical decisions.
  • Withings Health Solutions unveiled best practices for obesity care management programs built on a decade of partnerships across the segment. Those include: (1) continuous monitoring for real-time adjustments, (2) on-device communications, (3) data-driven outcome tracking, (4) addressing comorbidities, (5) measuring more than traditional BMI metrics. All great practices for maternal health as well!

Welcome to all the fresh faces scrolling through DHW for the first time, and shoutout to all the long-time readers we caught up with at the show – the OGs have officially been here longer than a lot of the exhibitors have existed!

We picked up as many announcements as we could carry, but if we missed anything exciting and you don’t see it below, hit reply and let us know what to circle back on next week.

2025 State of Digital Health Purchasing

What better way to kick off HLTH week than with a new survey from the Peterson Health Technology Institute showing that healthcare decision-makers are still hungry for new solutions?

PHTI’s 2025 State of Digital Health Purchasing Survey showed that health plans, employers, and health systems are all investing heavily in digital health, but spending patterns are starting to diverge.

  • The headlining stat: 61% of health plans and 44% of health systems plan on increasing digital health spending in the coming year, compared to just 14% of employers.

Employer spending has leveled off. Two-thirds of employers plan to hold spending steady as they maintain their current suite of solutions.

  • In contrast, health plans and health systems are ramping up to offer a wider variety of solutions (81%) and keep up with patient engagement (77%).
  • The top priorities across the board? Improve access, reduce costs, and strengthen user experiences, especially in areas like diabetes, mental health, and primary care.

Purchasers are more hawk-eyed than ever… especially when it comes to their contracts. Nearly half of purchasers are already using performance-based contracts, and the majority plan to use them in the next year.

  • 73% of contracts now have a duration under two years – up from 59% last year – leaving a short window for solutions to prove their value.
  • Short-term contracts, annual portfolio reviews, and a laser focus on engagement and ROI are the new normal. Building long-term relationships hinges on demonstrating both.

Vetting isn’t getting any easier. When comparing vendors, employers (66%) are more likely than health plans (23%) and health systems (42%) to cite cost as the deciding factor.

  • Payors and providers both prioritize a proven track record above cost, but the report points to other ways to gain an edge.
  • Although performance-based contracts are gaining traction, few purchasers are satisfied with their current models, and they’re looking for vendors that can offer either better outcome thresholds or attribution methods.

The Takeaway

Health plans, employers, and health systems all still have an appetite for new solutions, and PHTI just gave vendors a way to stack their decks with more data on each of their unique priorities.

2025 Trends Shaping the Health Economy

Trilliant Health just released its 2025 Trends Shaping the Health Economy Report, delivering a uniquely holistic perspective on the healthcare market through the lens of supply and demand.

Here’s the state of play. Health expenditures are growing faster than the rest of the economy, and they’re projected to represent 20.3% of GDP by 2033. 

  • The U.S. spends more and gets less than peer nations, which might have been tolerable when our federal debt was at $800B in 1980, but definitely isn’t now that it’s at $37T.

What levers can we pull? This year’s 115 page analysis looks into six macro trends driving the healthcare economy, and underlines each of them with concrete stories from real-world data.

  • 1) Affordability concerns are reshaping demand. Medical prices are up 54.5% since 2009, and they’re pressuring patients and employers to weigh their options – especially when rates for an inpatient procedure can vary as much as 7x within the same facility depending on the payor (p. 19).
  • 2) Stakeholders are slow to adapt to demographic trends. Mortality rates among adults aged 18-44 have been rising as the fertility rate falls, shrinking the share of Americans with employer-sponsored coverage (p. 22).
  • 3) Specialty care intervention is incentivized over primary care prevention. In 2024, behavioral health visits rose 11.4%, while primary care visits declined 5.6%, marking the first time behavioral health utilization surpassed primary care (p. 43).
  • 4) Fraud, waste, and abuse are pervasive. The share of high-complexity ED visits has risen sharply, increasing from 36.6% to 47.8% of visits between 2018 and 2024, underscoring the financial impact of upcoding (p. 57).
  • 5) Alternative therapies are accelerating. GLP-1 utilization increased 745% from 2018 to 2023, while bariatric surgery volumes were flat to declining, illustrating how high-margin procedures face growing competition from medications (p. 86).
  • 6) If the industry won’t deliver value, the government will. Federal programs have consistently failed to bend the cost curve (MSSP savings are less than 1% of Medicare spending), and there’s mounting political pressure for top-down structural reform (p. 89).

The Takeaway

The U.S. healthcare system is at a crossroads. As Trilliant put it so nicely, the choice for all health economy stakeholders is whether to implement “radical change from the inside” or “to be subjected to such change by external forces.”

Bain & Company: Top Healthcare IT Priorities

Payors and providers are fighting different operational battles, but they’re using the same two-letter weapon to come out on top: AI, you guessed it. 

A joint report from Bain & Company and KLAS found that 80% of payors and 70% of providers now have an AI strategy in place, up from just 60% last year.

  • Providers are up against structural workforce shortages and rising patient volumes, while payors are contending with higher medical loss ratios and more regulatory scrutiny.
  • Bain and KLAS’ survey of 228 U.S. healthcare execs suggests that all signs point to one solution, and that’s deploying tech to improve margins.

Where are payors investing? Care coordination (57%) and utilization management (55%) were the top IT investment priorities for the second straight year.

  • Payors place total cost of ownership, functionality, and scalability ahead of suite convenience, so best‑of‑breed is still the default buying motion.
  • Plans are leveraging AI for everything from member engagement (35%) and enrollment (26%) to risk adjustment (26%) and prior auth automation (20%).

Where are providers investing? Revenue. Cycle. Management.

  • Half of providers ranked RCM among their top IT priorities, placing it above clinical workflows (34%) and EHRs (32%).
  • RCM = ROI. Accurate documentation and coding results in cleaner claims and fewer denials, which directly translates to higher revenue and lower expenses.
  • It’s also a match made in heaven for AI automation, and RCM currently represents the four most common AI use cases: ambient documentation (62%), clinical documentation improvement (43%), coding (30%), and prior authorization (27%).

Here’s the kicker. Providers cite EHR integration and interoperability as their biggest pain points, so most of them prioritize their EHR vendors for new solutions.

  • Only 20% of providers are primarily best-of-breed buyers, and two-thirds of Epic customers would choose an Epic option that’s “good enough” over a better competing product.

The Takeaway

It’s getting pretty hard to not be bullish on AI. There’s still plenty of uncertainty, but both payors and providers now seem to agree that inaction is the riskiest action.

Rock Health Q3 Overview: Signals Out of Sync

Rock Health’s always-excellent digital health market overview painted an interesting picture for Q3, with venture funding continuing to climb despite several “signals out of sync.”

We’re steady on the surface. Digital health startups raised $3.5B across 107 deals in the third quarter, outpacing last year by a decent margin and bringing the year-to-date total to $9.9B across 351 rounds [Chart: Q3 Funding].

  • Deal volume continued to slow, but fewer raises yielded larger checks. Q3 saw 107 funding rounds, down from 120 in Q2 and 124 in Q1.
  • The average raise in 2025 now stands at $28.1M (up from $20.4M in 2024), and we’ve already seen 19 mega-rounds above $100M – surpassing last year’s total with a quarter left to go.

The middle is murky. Rock Health rolled up its sleeves and calculated widely variable trends in mid-market funding.

  • Series B deal flow has thinned, with just 30 raises through Q3, compared to an average of more than 60 annually over the past three years.
  • As fewer startups reach Series B, those that do are stretching the range of what a B round can be. Series B deal sizes so far in 2025 spanned $11M–$210M ($199M) – the widest spread since the boom of 2021.
  • Pair that with the persistent prevalence of unlabeled raises, and the thinning Series B pipeline suggests that startups are traveling increasingly winding roads to reach scale.

Activity is concentrating around workflows. The biggest theme of the Q3 report was that Clinical Workflow and Non-Clinical Workflow are now 2025’s two most-funded value propositions, capturing a combined 42% of the total funding [Chart: Value Propositions].

  • A $1.3B lead separates these value propositions from the rest of the pack, and workflow tools now appear to be in a league of their own.

Startups are heading horizontal. The report also highlighted a growing group of startups pushing into adjacent workflows, such as Abridge’s partnership with Highmark Health (expanding into prior auths) and Judi Health acquiring Amino (moving into patient navigation).

  • M&A volume is up 37% from last year, with 166 acquisitions through Q3 (already topping 2024’s 121 total), in large part due to these horizontal moves. 

The Takeaway

The numbers look steady, but the market is also steadily splitting in half. That means that the real story going forward won’t be whether digital health startups can attract investors (they can), but whether companies can demonstrate the impact needed to land on the right side of the divide. 

Get the top digital health stories right in your inbox